INIFY Laboratories AB

OSL • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 16:25

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangeOSL

Market Capitalization655.6 mln

Float107 mln

Earnings Date10/28/2026

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-2.39

Borderline

Relative Strength

3 / 100

Severely lagging

Pre-Tax Margin

-333%

Severely loss-making

ROE

-63.27

Deeply negative

Altman Z-Score

21.76

Exceptional

Business Description

INIFY Laboratories AB is a Stockholm-based company founded in 2021 that specializes in detecting prostate cancer for patients in Sweden.

Key Fundamentals

EPS-1.02

ROE-63.27

ROIC-105

ROA-53.49

EBITDA, mln-71.99

EV / EBITDA-6.59

EV / EBIT-5.75

Revenue, mln24.82

EV / Revenue19.11

Quote Details

Last 5.00

Change -0.45 (-8.26%)

Open 4.92

Volume 1,287

Turnover 6,435

Average Volume 3,021.43

Financial Ratios

Pre-Tax Profit Margin-333

Current Ratio6.90

Price / Book3.49

Price / Tangible Book3.51

Price / Sales17.26

Financial Strength

Altman Z-Score21.76

Piotroski F-Score 4 / 9

Beneish M-Score-2.39

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-16.67%	1 / 100
1 Month	-12.28%	11 / 100
2 Months	-32.43%	4 / 100
6 Months	25%	86 / 100
1 Year	-8.26%	30 / 100